Biotech Firm Revolutionizing Amino-Acid Manufacturing Closes $12 Million Series A Financing Round
SAN LEANDRO, CA — Aralez Bio, a platform technology company with a proprietary enzymatic approach for designing and manufacturing noncanonical amino acids (ncAAs), announced the close of its oversubscribed $12 million Series A financing today. The round was led by Spero Ventures with matched investment from Paladin Capital Group. Additional investors included Good Growth Capital, Astia […]